Displaying results 1 - 3 of 3
-
Letter to the Meaningful Use Workgroup of the Health Information Technology Policy Committee
Content Type: Letter
Sent on March 3, 2014, this letter summarizes the ISDS Board of Directors' response to preliminary recommendations that Laboratory Reporting and Syndromic Surveillance be removed as core measures for Eligible Hospitals in Stage 3 Meaningful Use. The… read more… laboratory reporting and syndromic surveillance may slow or even stop the growing momentum to set … test data and not gone into production, there may be no incentive for the provider to achieve … unfiltered deidentified records representing all visits to the hospital’s emergency department, or … -
Letter to BioSense Governance Group Re: Recommendations for improving BioSense's data sharing capability
Content Type: Letter
This letter was intended to establish a dialogue between surveillance professionals and the BioSense Governance Group. The particiapnts were interested in establishing data sharing relationships across jurisdictions utilizing BioSense… read more… Submitted by uysz on Mon, 10/23/2017 - 10:00 … May 2013 ISDS Data Sharing Workshop Participants c/o … address these and future recommendations. On May 20-‐21, 2013, the International Society for … data only? What are the normal number of ED visits in a day? What proportion of the … -
Letter to the Center for Medicaid Services (CMS)
Content Type: Letter
This letter from ISDS offers Comments from on proposed rule for meaningful use Medicare and Medicaid Programs Electronic Health Record Incentive Program 42CFR Parts 412, 413, 422, and 495 CMSB0033BP. RIN 0938BAP78. read more… EHR REPORTING PERIOD. MORE STRINGENT REQUIREMENTS MAY BE ESTABLISHED FOR HOSPITALS UNDER THE MEDICAID … IN THE MEDICAID EHR INCENTIVE PROGRAM. STATES MAY PROPOSE ANY MODIFICATION OR ADDITION TO CMS IN …